Grgurinovich N
Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park, Australia.
J Anal Toxicol. 1988 Jan-Feb;12(1):38-41. doi: 10.1093/jat/12.1.38.
A simple and sensitive high-performance liquid chromatographic method for the analysis of flecainide in plasma has been developed. Alkalinized plasma was extracted with 1-chlorobutane and then back extracted into dilute phosphoric acid. An aliquot of the aqueous acid layer was injected onto the HPLC column and the eluent monitored at 297 nm. A phenyl reversed-phase column was used for the separation. The mobile phase was 42% acetonitrile and 58% 20mM sodium acetate solution, with the pH of the mobile phase adjusted to 6.5. The recovery of flecainide was 88.5%, and the coefficient of variation of two quality control (0.2 mg/L and 1.0 mg/L) samples analyzed on a within-day basis (N = 10) was 3.0% in both cases. The coefficient of variation for the two quality control samples analyzed on a between-day basis (N = 10) was less than 10% in both cases. The limit of sensitivity for the assay was 0.033 mg/L. A variety of other drugs likely to be used in patients with cardiovascular disease were screened and found not to interfere with the assay.
已开发出一种用于分析血浆中氟卡尼的简单、灵敏的高效液相色谱法。碱化血浆用1-氯丁烷萃取,然后反萃取到稀磷酸中。取一份水相酸层注入高效液相色谱柱,在297nm处监测洗脱液。使用苯基反相柱进行分离。流动相为42%乙腈和58% 20mM醋酸钠溶液,流动相pH值调至6.5。氟卡尼的回收率为88.5%,日内分析两个质量控制样品(0.2mg/L和1.0mg/L)(N = 10)的变异系数在两种情况下均为3.0%。日间分析两个质量控制样品(N = 10)的变异系数在两种情况下均小于10%。该测定法的灵敏度极限为0.033mg/L。对心血管疾病患者可能使用的多种其他药物进行了筛选,发现它们不干扰该测定法。